STAT5B and lymphoma: The study of the underlying pathological context, the cytogenetical and TCR-γ clonality analyses and the search of mutations in the SH2 domain of STAT3 and STAT5b should help to distinguish LGL leukemia or other malignant lymphomas from non clonal CD8+ T-cell expansions.